Patrizia Sini

1.9k total citations
21 papers, 917 citations indexed

About

Patrizia Sini is a scholar working on Molecular Biology, Cell Biology and Oncology. According to data from OpenAlex, Patrizia Sini has authored 21 papers receiving a total of 917 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 9 papers in Cell Biology and 7 papers in Oncology. Recurrent topics in Patrizia Sini's work include Microtubule and mitosis dynamics (5 papers), Cancer-related Molecular Pathways (5 papers) and PI3K/AKT/mTOR signaling in cancer (3 papers). Patrizia Sini is often cited by papers focused on Microtubule and mitosis dynamics (5 papers), Cancer-related Molecular Pathways (5 papers) and PI3K/AKT/mTOR signaling in cancer (3 papers). Patrizia Sini collaborates with scholars based in Austria, Italy and United Kingdom. Patrizia Sini's co-authors include Maria Enrica Tira, Giorgio Scita, Pier Paolo Di Fiore, Angela Cannas, Anthony J. Koleske, Sylvie M. Guichard, Christine M. Chresta, Dominic I. James, Christian Schnell and Terence O’Reilly and has published in prestigious journals such as The Journal of Cell Biology, Nature Cell Biology and Cancer Research.

In The Last Decade

Patrizia Sini

21 papers receiving 901 citations

Peers

Patrizia Sini
Sophie Astrof United States
Silvana Libertini United Kingdom
Rachel L. Dusek United States
Sharon Klein United States
Martin Degen Switzerland
Maria E. Vega United States
Sophie Astrof United States
Patrizia Sini
Citations per year, relative to Patrizia Sini Patrizia Sini (= 1×) peers Sophie Astrof

Countries citing papers authored by Patrizia Sini

Since Specialization
Citations

This map shows the geographic impact of Patrizia Sini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrizia Sini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrizia Sini more than expected).

Fields of papers citing papers by Patrizia Sini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrizia Sini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrizia Sini. The network helps show where Patrizia Sini may publish in the future.

Co-authorship network of co-authors of Patrizia Sini

This figure shows the co-authorship network connecting the top 25 collaborators of Patrizia Sini. A scholar is included among the top collaborators of Patrizia Sini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrizia Sini. Patrizia Sini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chambers, Toby L., Nicholas P. Greene, Antonio Filareto, et al.. (2025). At the Nexus Between Epigenetics and Senescence: The Effects of Senolytic ( BI01 ) Administration on DNA Methylation Clock Age and the Methylome in Aged and Regenerated Skeletal Muscle. Aging Cell. 24(7). e70068–e70068. 1 indexed citations
2.
Liu, Dongli, Cassandra J. Vandenberg, Patrizia Sini, et al.. (2025). The antibody–drug conjugate targeting ROR1, NBE-002, is active in high-grade serous ovarian cancer preclinical models. Therapeutic Advances in Medical Oncology. 17. 22777207–22777207. 1 indexed citations
3.
Yoh, Kiyotaka, Frans L. Opdam, Dieter Maier, et al.. (2025). 491P Zongertinib in HER2-altered gastrointestinal cancers: Preclinical activity and clinical findings from a phase Ia study. Annals of Oncology. 36. S185–S185. 1 indexed citations
4.
Raso, Maria Gabriela, Kurt W. Evans, Rossana Lazcano, et al.. (2024). Heterogeneous Profile of ROR1 Protein Expression across Tumor Types. Cancers. 16(10). 1874–1874. 6 indexed citations
5.
Sini, Patrizia, Ulrich Gürtler, Stephan K. Zahn, et al.. (2016). Pharmacological Profile of BI 847325, an Orally Bioavailable, ATP-Competitive Inhibitor of MEK and Aurora Kinases. Molecular Cancer Therapeutics. 15(10). 2388–2398. 28 indexed citations
6.
Sini, Patrizia, et al.. (2015). The Novel ATP-Competitive MEK/Aurora Kinase Inhibitor BI-847325 Overcomes Acquired BRAF Inhibitor Resistance through Suppression of Mcl-1 and MEK Expression. Molecular Cancer Therapeutics. 14(6). 1354–1364. 34 indexed citations
7.
Alférez, Denis, Robert A. Goodlad, Rajesh Odedra, et al.. (2012). Inhibition of Aurora-B kinase activity confers antitumor efficacy in preclinical mouse models of early and advanced gastrointestinal neoplasia. International Journal of Oncology. 41(4). 1475–1485. 11 indexed citations
8.
Sini, Patrizia, Ulrich Gürtler, Stephan K. Zahn, et al.. (2012). Abstract 1919: Pharmacological characterization of BI 847325, a dual inhibitor of MEK and Aurora kinases. Cancer Research. 72(8_Supplement). 1919–1919. 1 indexed citations
9.
Azzariti, Amalia, Guido Bocci, Letizia Porcelli, et al.. (2011). Aurora B kinase inhibitor AZD1152: determinants of action and ability to enhance chemotherapeutics effectiveness in pancreatic and colon cancer. British Journal of Cancer. 104(5). 769–780. 54 indexed citations
10.
Sini, Patrizia, Dominic I. James, Christine M. Chresta, & Sylvie M. Guichard. (2010). Simultaneous inhibition of mTORC1 and mTORC2 by mTOR kinase inhibitor AZD8055 induces autophagy and cell death in cancer cells. Autophagy. 6(4). 553–554. 75 indexed citations
11.
Lane, Heidi A., Jeanette M. Wood, Paul M.J. McSheehy, et al.. (2009). mTOR Inhibitor RAD001 (Everolimus) Has Antiangiogenic/Vascular Properties Distinct from a VEGFR Tyrosine Kinase Inhibitor. Clinical Cancer Research. 15(5). 1612–1622. 196 indexed citations
12.
Samaržija, Ivana, Patrizia Sini, Thomas Schlange, Gwen MacDonald, & Nancy E. Hynes. (2009). Wnt3a regulates proliferation and migration of HUVEC via canonical and non-canonical Wnt signaling pathways. Biochemical and Biophysical Research Communications. 386(3). 449–454. 57 indexed citations
13.
Cummings, Jeffrey L., Cassandra L. Hodgkinson, Rajesh Odedra, et al.. (2008). Preclinical evaluation of M30 and M65 ELISAs as biomarkers of drug induced tumor cell death and antitumor activity. Molecular Cancer Therapeutics. 7(3). 455–463. 50 indexed citations
14.
Sini, Patrizia, Angela Cannas, Anthony J. Koleske, Pier Paolo Di Fiore, & Giorgio Scita. (2004). Abl-dependent tyrosine phosphorylation of Sos-1 mediates growth-factor-induced Rac activation. Nature Cell Biology. 6(3). 268–274. 106 indexed citations
15.
Tenni, Ruggero, Manuela Viola, Patrizia Sini, et al.. (2002). Interaction of decorin with CNBr peptides from collagens I and II. European Journal of Biochemistry. 269(5). 1428–1437. 44 indexed citations
16.
Scita, Giorgio, Pierluigi Tenca, Liliana B. Areces, et al.. (2001). An effector region in Eps8 is responsible for the activation of the Rac-specific GEF activity of Sos-1 and for the proper localization of the Rac-based actin–polymerizing machine. The Journal of Cell Biology. 154(5). 1031–1044. 110 indexed citations
17.
Sini, Patrizia, et al.. (1999). Effect of polydeoxyribonucleotides on human fibroblasts in primary culture. Cell Biochemistry and Function. 17(2). 107–114. 78 indexed citations
18.
Modena, Tiziana, Bice Conti, Ida Genta, et al.. (1998). Hyaluronidase-injectable microparticles intended for the treatment of extravasation. Journal of Microencapsulation. 15(1). 85–92. 8 indexed citations
19.
Sini, Patrizia, et al.. (1997). Role of decorin on in vitro fibrillogenesis of type I collagen. Glycoconjugate Journal. 14(7). 871–874. 40 indexed citations
20.
Sini, Patrizia, et al.. (1995). Structural heterogeneity of dermatan sulfate chains: Correlation with heparin cofactor II activating properties. Thrombosis Research. 79(2). 187–198. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026